Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03856099
Title TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors PharmAbcine
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Stanford Avanced Medical Center Stanford California 94305 United States Details
Florida Hospital Cancer Institute & Florida Hospital Orlando Orlando Florida 32804 United States Details
Austin Hospital Heidelberg Victoria 3084 Australia Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field